Shingo Yano

12PUBLICATIONS
70CO-AUTHORS
HaematologyGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 27, 2026
Donor age as a dual-risk factor for donor safety and recipient survival in allogeneic haematopoietic stem cell transplantation.

|Jul 09, 2026
Schlafen 11 Is Overexpressed in Multiple Myeloma and Undergoes Nucleolar Translocation in Response to Bortezomib.

|Jun 18, 2026
Treatment-Free Remission and Immune Profiling after Frontline Second-Generation TKI Therapy in CML.

|Sep 15, 2025
Impact of prior solid tumors and their treatment modality on outcomes after allogeneic hematopoietic stem cell transplantation.

Takayuki Fujii, Masatoshi Sakurai, Hiroaki Shimizu

|Apr 04, 2025
Improved post-transplant outcomes for elderly acute myeloid leukemia patients conditioned with FLU/BU4 rather than conventional MAC regimens.

Takuya Shimizu, Yasuyuki Arai, Tadakazu Kondo

|Jan 21, 2025
Myeloablative conditioning in cord blood transplantation for acute myeloid leukemia patients is efficacious only until age 55.

Shinichiro Oshima, Yasuyuki Arai, Tadakazu Kondo

Pageof 2

Frequent Collaborators

9 joint publications

Yoshiko Atsuta

5 joint publications

Makoto Onizuka

5 joint publications

Masamitsu Yanada

5 joint publications

Naoyuki Uchida